Tranzyme (TZYM)
Add to Watchlists Create an AlertTranzyme Profit Margin Quarterly:
-302.4% for Dec. 31, 2012Tranzyme Historical Profit Margin Quarterly Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -302.4% |
| Sept. 30, 2012 | -217.2% |
| June 30, 2012 | -232.6% |
| March 31, 2012 | -322.9% |
| Dec. 31, 2011 | -362.8% |
| Sept. 30, 2011 | -242.4% |
| June 30, 2011 | -148.3% |
| March 31, 2011 | -143.9% |
| Dec. 31, 2010 | -38.98% |
| Sept. 30, 2010 | -67.37% |
| June 30, 2010 | -100.2% |
| March 31, 2010 | -190.5% |
| Dec. 31, 2009 | -350.8% |
About Profit Margin
Profit margin represents the percentage of revenue that a company keeps as profit after accounting for fixed and variable costs. It is calculated by dividing net income by revenue. The profit margin is mainly used for internal comparisons, because acceptable profit margins vary between industries. In general, narrow profit margins indicate increased volatile earnings. For companies with significant fixed costs, wide profit margins reduce the risk that a decline in sales will cause a net profit loss.
Displayed as a percentage, profit margin can be thought as the amount of profit that a company keeps per dollar of revenue. For example, if a company has a profit margin of 43%, the company keeps $.43 of each dollar of revenue.
Learn More
TZYM Profit Margin Quarterly Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | 14.85% |
| Zoetis | 12.84% |
| AbbVie | 22.36% |
TZYM Profit Margin Quarterly Rankings
| Overall |
38th percentile 4705 of 7600 |
| Sector |
36th percentile 416 of 653 in Healthcare |
| Industry |
41st percentile 31 of 53 in Drug Manufacturers - Major |
TZYM Profit Margin Quarterly Range, Past 5 Years
| Minimum | -362.8% | Dec 2011 |
| Maximum | -38.98% | Dec 2010 |
| Average | -209.2% |
